This page gives an overview of some of the diabetes-related stories we have seen in the news this month. We especially look out for a newsworthy story focussing on medtech and sensor technology.
The Omnipod 5 which has been awarded a European CE mark. Insulet announced that it will be marketed in Europe from mid-2023 although it’s not yet known which countries will be prioritised.
Find out more on the website here: https://www.omnipod.com/en-gb/what-is-omnipod/omnipod-5
Note: the Ominipod 5 started to be rolled out in the USA in August 2022 and can be bought direct from pharmacies.
Image courtesy of GlucoRx.
GlucoRx announced the first non-invasive glucose monitor, the GlucoRx Biosensor™ developed with Cardiff University. This is a sensor with no needle insertion or filament!
A recent statistical reminder by Partha Kar (NHS Diabetes Specialist) shows that type 1 diabetes isn't a condition that only affects the young and in fact over 60% of those struggling with diabetes management are over 40 years old!
TYPE 1 DIABETES BY AGE
Data 2020 Feb #gbdoc
GLUCOMEN DAY PRICES
As previously reported, GlucoMen Day CGM will be available on prescription (subject to areas putting it on their prescribing list) from September 2022. The cost to the NHS is slightly less than Libre and Dexcom ONE at £67 for a pack of 2 (ie. £33.50 each).
Find out how GlucoMen Day could help your diabetes management in our blog detailing all the pros and cons here.
Read August News: Click here.
Read July News: Click here.
Read June News: Click here.
Read May News: Click here.
Read April News: Click here.
Read March News: Click here.
Read February News: Click here.
Read January News: Click here.